With improvement in medical, interventional, and surgical therapies for congenital heart
disease (CHD), most patients with CHD are surviving into adulthood such that there are now …

In the United States, children living with congenital heart disease (CHD) are outnumbered
by adults with CHD (ACHD). Due to surgical and medical advances, it is now estimated that …

Although “congenital heart disease” incorporates a broad and diverse spectrum of inborn
cardiac disorders, one shared feature is the propensity for cardiac arrhythmias, albeit to …

Remarkable medical and surgical breakthroughs in the care of children born with heart
defects have resulted in a striking improvement in survival, particularly in younger age strata …

Heart failure (HF) accounts for one-quarter of deaths in the adult congenital heart disease
(ACHD) population. 1 In parallel with a dramatic increase in the number of hospitalizations …

Together, heart failure and arrhythmia represent the most important cardiovascular sources
of morbidity and mortality among adults with congenital heart disease (ACHDs). Although …

Heart failure therapy, while well tested in the adult population, therapeutic interventions are
less well defined in the pediatric population. Several treatment strategies are available for …

The past 60 years have brought remarkable advancements in the diagnosis and treatment of
congenital heart disease (CHD). Early diagnosis and improvements in cardiac surgery and …

Congenital heart disease (CHD) is the most common global congenital defect affecting over
2.4 million individuals in the United States. Ongoing medical and surgical advancements …

Congenital heart disease (CHD) is present in 1% of all live births. 1, 2 Although the birth
incidence of CHD has not changed over time, there has been a significant improvement in …